These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32810258)

  • 1. The characteristics of patients with possible familial hypercholesterolemia: screening a large payer/provider healthcare delivery system.
    Watanabe A; Ito H
    QJM; 2021 Feb; 114(1):66. PubMed ID: 32810258
    [No Abstract]   [Full Text] [Related]  

  • 2. The characteristics of patients with possible familial hypercholesterolemia: screening a large payer/provider healthcare delivery system.
    Elis A
    QJM; 2021 Feb; 114(1):67. PubMed ID: 32810264
    [No Abstract]   [Full Text] [Related]  

  • 3. [Familial hypercholesterolemia: why screening, counselling and treatment should be integrated].
    Roeters van Lennep JE; Visseren FL; Jira PE
    Ned Tijdschr Geneeskd; 2015; 159():A8875. PubMed ID: 26013253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics of patients with possible familial hypercholesterolemia-screening a large payer/provider healthcare delivery system.
    Elis A; Leventer-Roberts M; Bachrach A; Lieberman N; Durst R; Knobler H; Balicer R
    QJM; 2020 Jun; 113(6):411-417. PubMed ID: 31883017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design.
    Češka R; Paragh G; Reiner Ž; Banach M; Tokgözoğlu L; Susekov AV; Rašlová K; Freiberger T; Vohnout B; Rynkiewicz A; Goudev A; Dan GA; Gaiţă D; Pojskić B; Pećin I; Kayıkçıoğlu M; Mitchenko O; Ezhov MV; Latkovskis G; Petrulionienė Ž; Fras Z; Tasić N; Mirrakhimov EM; Murataliev T; Shek AB; Tuka V; Tselepis AD; Moubarak EM; Rasadi KA
    Vnitr Lek; 2017; 63(1):43-48. PubMed ID: 28225290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia.
    McGowan MP; Hosseini Dehkordi SH; Moriarty PM; Duell PB
    J Am Heart Assoc; 2019 Dec; 8(24):e013225. PubMed ID: 31838973
    [No Abstract]   [Full Text] [Related]  

  • 8. What Should Be the Screening Strategy for Familial Hypercholesterolemia?
    McCrindle BW; Gidding SS
    N Engl J Med; 2016 Oct; 375(17):1685-1686. PubMed ID: 27783919
    [No Abstract]   [Full Text] [Related]  

  • 9. Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    Khera AV; Kathiresan S
    N Engl J Med; 2017 Feb; 376(5):498-9. PubMed ID: 28150925
    [No Abstract]   [Full Text] [Related]  

  • 10. Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    Martin AC; Watts GF
    N Engl J Med; 2017 Feb; 376(5):498. PubMed ID: 28150923
    [No Abstract]   [Full Text] [Related]  

  • 11. Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    Kullo IJ; Safarova MS
    N Engl J Med; 2017 Feb; 376(5):498. PubMed ID: 28150922
    [No Abstract]   [Full Text] [Related]  

  • 12. Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    Hingorani AD; Futema M; Humphries S
    N Engl J Med; 2017 Feb; 376(5):499. PubMed ID: 28146662
    [No Abstract]   [Full Text] [Related]  

  • 13. Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    Wald DS; Bestwick JP; Wald NJ
    N Engl J Med; 2017 Feb; 376(5):499-500. PubMed ID: 28146661
    [No Abstract]   [Full Text] [Related]  

  • 14. [CME: Primary and Secondary Hypercholesterolemia].
    Hofbauer S; Wiesli P
    Praxis (Bern 1994); 2020 Aug; 109(10):755-762. PubMed ID: 32752965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Essential Role of Primary Caregiver in Early Detection of Familial Hypercholesterolemia and Cardiovascular Prevention.
    St-Pierre J; Ruel I; Genest J
    Curr Pediatr Rev; 2017; 13(4):260-264. PubMed ID: 29473516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic.
    Stempel H; Dodge A; Marriott E; Peterson AL
    J Pediatr; 2016 Nov; 178():285-287. PubMed ID: 27592098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercholesterolemia in children: Why and how to screen for it?
    Girardet JP; Bocquet A; Chouraqui JP; Darmaun D; Feillet F; Frelut ML; Hankard R; Rozé JC; Simeoni U; Turck D; Briend A; Dupont C;
    Arch Pediatr; 2018 Apr; 25(3):175-176. PubMed ID: 29548557
    [No Abstract]   [Full Text] [Related]  

  • 18. Future issues, public policy, and public awareness of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Goldberg AC; Robinson JG; Cromwell WC; Ross JL; Ziajka PE
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S46-51. PubMed ID: 21600529
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and Management of Heterozygous Familial Hypercholesterolemia. Proceedings of a workshop. July 20-21, 1992.
    Am J Cardiol; 1993 Sep; 72(10):1D-84D. PubMed ID: 8105672
    [No Abstract]   [Full Text] [Related]  

  • 20. [Familial hypercholesterolemia. Proposed measures favoring systematic screening].
    Sabourin G
    Perspect Infirm; 2015; 12(3):14. PubMed ID: 26079033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.